Global Cancer Antibody Drug Conjugates Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cancer Antibody Drug Conjugates Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cancer Antibody Drug Conjugates by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cancer Antibody Drug Conjugates by Country/Region, 2017, 2022 & 2028

2.2 Cancer Antibody Drug Conjugates Segment by Type

2.2.1 First & Second Generation ADCs

2.2.2 Third Generation ADCs

2.3 Cancer Antibody Drug Conjugates Sales by Type

2.3.1 Global Cancer Antibody Drug Conjugates Sales Market Share by Type (2017-2022)

2.3.2 Global Cancer Antibody Drug Conjugates Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cancer Antibody Drug Conjugates Sale Price by Type (2017-2022)

2.4 Cancer Antibody Drug Conjugates Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Cancer Antibody Drug Conjugates Sales by Application

2.5.1 Global Cancer Antibody Drug Conjugates Sale Market Share by Application (2017-2022)

2.5.2 Global Cancer Antibody Drug Conjugates Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cancer Antibody Drug Conjugates Sale Price by Application (2017-2022)

3 Global Cancer Antibody Drug Conjugates by Company

3.1 Global Cancer Antibody Drug Conjugates Breakdown Data by Company

3.1.1 Global Cancer Antibody Drug Conjugates Annual Sales by Company (2020-2022)

3.1.2 Global Cancer Antibody Drug Conjugates Sales Market Share by Company (2020-2022)

3.2 Global Cancer Antibody Drug Conjugates Annual Revenue by Company (2020-2022)

3.2.1 Global Cancer Antibody Drug Conjugates Revenue by Company (2020-2022)

3.2.2 Global Cancer Antibody Drug Conjugates Revenue Market Share by Company (2020-2022)

3.3 Global Cancer Antibody Drug Conjugates Sale Price by Company

3.4 Key Manufacturers Cancer Antibody Drug Conjugates Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cancer Antibody Drug Conjugates Product Location Distribution

3.4.2 Players Cancer Antibody Drug Conjugates Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cancer Antibody Drug Conjugates by Geographic Region

4.1 World Historic Cancer Antibody Drug Conjugates Market Size by Geographic Region (2017-2022)

4.1.1 Global Cancer Antibody Drug Conjugates Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cancer Antibody Drug Conjugates Annual Revenue by Geographic Region

4.2 World Historic Cancer Antibody Drug Conjugates Market Size by Country/Region (2017-2022)

4.2.1 Global Cancer Antibody Drug Conjugates Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cancer Antibody Drug Conjugates Annual Revenue by Country/Region

4.3 Americas Cancer Antibody Drug Conjugates Sales Growth

4.4 APAC Cancer Antibody Drug Conjugates Sales Growth

4.5 Europe Cancer Antibody Drug Conjugates Sales Growth

4.6 Middle East & Africa Cancer Antibody Drug Conjugates Sales Growth

5 Americas

5.1 Americas Cancer Antibody Drug Conjugates Sales by Country

5.1.1 Americas Cancer Antibody Drug Conjugates Sales by Country (2017-2022)

5.1.2 Americas Cancer Antibody Drug Conjugates Revenue by Country (2017-2022)

5.2 Americas Cancer Antibody Drug Conjugates Sales by Type

5.3 Americas Cancer Antibody Drug Conjugates Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cancer Antibody Drug Conjugates Sales by Region

6.1.1 APAC Cancer Antibody Drug Conjugates Sales by Region (2017-2022)

6.1.2 APAC Cancer Antibody Drug Conjugates Revenue by Region (2017-2022)

6.2 APAC Cancer Antibody Drug Conjugates Sales by Type

6.3 APAC Cancer Antibody Drug Conjugates Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cancer Antibody Drug Conjugates by Country

7.1.1 Europe Cancer Antibody Drug Conjugates Sales by Country (2017-2022)

7.1.2 Europe Cancer Antibody Drug Conjugates Revenue by Country (2017-2022)

7.2 Europe Cancer Antibody Drug Conjugates Sales by Type

7.3 Europe Cancer Antibody Drug Conjugates Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cancer Antibody Drug Conjugates by Country

8.1.1 Middle East & Africa Cancer Antibody Drug Conjugates Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cancer Antibody Drug Conjugates Revenue by Country (2017-2022)

8.2 Middle East & Africa Cancer Antibody Drug Conjugates Sales by Type

8.3 Middle East & Africa Cancer Antibody Drug Conjugates Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cancer Antibody Drug Conjugates

10.3 Manufacturing Process Analysis of Cancer Antibody Drug Conjugates

10.4 Industry Chain Structure of Cancer Antibody Drug Conjugates

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cancer Antibody Drug Conjugates Distributors

11.3 Cancer Antibody Drug Conjugates Customer

12 World Forecast Review for Cancer Antibody Drug Conjugates by Geographic Region

12.1 Global Cancer Antibody Drug Conjugates Market Size Forecast by Region

12.1.1 Global Cancer Antibody Drug Conjugates Forecast by Region (2023-2028)

12.1.2 Global Cancer Antibody Drug Conjugates Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cancer Antibody Drug Conjugates Forecast by Type

12.7 Global Cancer Antibody Drug Conjugates Forecast by Application

13 Key Players Analysis

13.1 Novartis

13.1.1 Novartis Company Information

13.1.2 Novartis Cancer Antibody Drug Conjugates Product Offered

13.1.3 Novartis Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis Main Business Overview

13.1.5 Novartis Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Cancer Antibody Drug Conjugates Product Offered

13.2.3 Merck Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Roche

13.3.1 Roche Company Information

13.3.2 Roche Cancer Antibody Drug Conjugates Product Offered

13.3.3 Roche Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Roche Main Business Overview

13.3.5 Roche Latest Developments

13.4 AbbVie

13.4.1 AbbVie Company Information

13.4.2 AbbVie Cancer Antibody Drug Conjugates Product Offered

13.4.3 AbbVie Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AbbVie Main Business Overview

13.4.5 AbbVie Latest Developments

13.5 UCB

13.5.1 UCB Company Information

13.5.2 UCB Cancer Antibody Drug Conjugates Product Offered

13.5.3 UCB Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 UCB Main Business Overview

13.5.5 UCB Latest Developments

13.6 Bristol-Myers Squibb

13.6.1 Bristol-Myers Squibb Company Information

13.6.2 Bristol-Myers Squibb Cancer Antibody Drug Conjugates Product Offered

13.6.3 Bristol-Myers Squibb Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bristol-Myers Squibb Main Business Overview

13.6.5 Bristol-Myers Squibb Latest Developments

13.7 Stem CentRx

13.7.1 Stem CentRx Company Information

13.7.2 Stem CentRx Cancer Antibody Drug Conjugates Product Offered

13.7.3 Stem CentRx Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Stem CentRx Main Business Overview

13.7.5 Stem CentRx Latest Developments

13.8 Biogen Idec

13.8.1 Biogen Idec Company Information

13.8.2 Biogen Idec Cancer Antibody Drug Conjugates Product Offered

13.8.3 Biogen Idec Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Biogen Idec Main Business Overview

13.8.5 Biogen Idec Latest Developments

13.9 Nordic Nanovector

13.9.1 Nordic Nanovector Company Information

13.9.2 Nordic Nanovector Cancer Antibody Drug Conjugates Product Offered

13.9.3 Nordic Nanovector Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Nordic Nanovector Main Business Overview

13.9.5 Nordic Nanovector Latest Developments

13.10 Millennium

13.10.1 Millennium Company Information

13.10.2 Millennium Cancer Antibody Drug Conjugates Product Offered

13.10.3 Millennium Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Millennium Main Business Overview

13.10.5 Millennium Latest Developments

13.11 Biotest AG

13.11.1 Biotest AG Company Information

13.11.2 Biotest AG Cancer Antibody Drug Conjugates Product Offered

13.11.3 Biotest AG Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Biotest AG Main Business Overview

13.11.5 Biotest AG Latest Developments

13.12 PDL BioPharma

13.12.1 PDL BioPharma Company Information

13.12.2 PDL BioPharma Cancer Antibody Drug Conjugates Product Offered

13.12.3 PDL BioPharma Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 PDL BioPharma Main Business Overview

13.12.5 PDL BioPharma Latest Developments

13.13 Progenics Pharmaceuticals

13.13.1 Progenics Pharmaceuticals Company Information

13.13.2 Progenics Pharmaceuticals Cancer Antibody Drug Conjugates Product Offered

13.13.3 Progenics Pharmaceuticals Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Progenics Pharmaceuticals Main Business Overview

13.13.5 Progenics Pharmaceuticals Latest Developments

13.14 Seattle Genetics

13.14.1 Seattle Genetics Company Information

13.14.2 Seattle Genetics Cancer Antibody Drug Conjugates Product Offered

13.14.3 Seattle Genetics Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Seattle Genetics Main Business Overview

13.14.5 Seattle Genetics Latest Developments

13.15 Viventia Biotechnologies

13.15.1 Viventia Biotechnologies Company Information

13.15.2 Viventia Biotechnologies Cancer Antibody Drug Conjugates Product Offered

13.15.3 Viventia Biotechnologies Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Viventia Biotechnologies Main Business Overview

13.15.5 Viventia Biotechnologies Latest Developments

13.16 AbGenomics Corporation

13.16.1 AbGenomics Corporation Company Information

13.16.2 AbGenomics Corporation Cancer Antibody Drug Conjugates Product Offered

13.16.3 AbGenomics Corporation Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 AbGenomics Corporation Main Business Overview

13.16.5 AbGenomics Corporation Latest Developments

13.17 Helix BioPharma

13.17.1 Helix BioPharma Company Information

13.17.2 Helix BioPharma Cancer Antibody Drug Conjugates Product Offered

13.17.3 Helix BioPharma Cancer Antibody Drug Conjugates Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Helix BioPharma Main Business Overview

13.17.5 Helix BioPharma Latest Developments

14 Research Findings and Conclusion

Table 1. Cancer Antibody Drug Conjugates Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cancer Antibody Drug Conjugates Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of First & Second Generation ADCs

Table 4. Major Players of Third Generation ADCs

Table 5. Global Cancer Antibody Drug Conjugates Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Cancer Antibody Drug Conjugates Sales Market Share by Type (2017-2022)

Table 7. Global Cancer Antibody Drug Conjugates Revenue by Type (2017-2022) & ($ million)

Table 8. Global Cancer Antibody Drug Conjugates Revenue Market Share by Type (2017-2022)

Table 9. Global Cancer Antibody Drug Conjugates Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Cancer Antibody Drug Conjugates Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Cancer Antibody Drug Conjugates Sales Market Share by Application (2017-2022)

Table 12. Global Cancer Antibody Drug Conjugates Revenue by Application (2017-2022)

Table 13. Global Cancer Antibody Drug Conjugates Revenue Market Share by Application (2017-2022)

Table 14. Global Cancer Antibody Drug Conjugates Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Cancer Antibody Drug Conjugates Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Cancer Antibody Drug Conjugates Sales Market Share by Company (2020-2022)

Table 17. Global Cancer Antibody Drug Conjugates Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Cancer Antibody Drug Conjugates Revenue Market Share by Company (2020-2022)

Table 19. Global Cancer Antibody Drug Conjugates Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Cancer Antibody Drug Conjugates Producing Area Distribution and Sales Area

Table 21. Players Cancer Antibody Drug Conjugates Products Offered

Table 22. Cancer Antibody Drug Conjugates Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Cancer Antibody Drug Conjugates Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Cancer Antibody Drug Conjugates Sales Market Share Geographic Region (2017-2022)

Table 27. Global Cancer Antibody Drug Conjugates Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Cancer Antibody Drug Conjugates Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Cancer Antibody Drug Conjugates Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Cancer Antibody Drug Conjugates Sales Market Share by Country/Region (2017-2022)

Table 31. Global Cancer Antibody Drug Conjugates Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Cancer Antibody Drug Conjugates Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Cancer Antibody Drug Conjugates Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Cancer Antibody Drug Conjugates Sales Market Share by Country (2017-2022)

Table 35. Americas Cancer Antibody Drug Conjugates Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Cancer Antibody Drug Conjugates Revenue Market Share by Country (2017-2022)

Table 37. Americas Cancer Antibody Drug Conjugates Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Cancer Antibody Drug Conjugates Sales Market Share by Type (2017-2022)

Table 39. Americas Cancer Antibody Drug Conjugates Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Cancer Antibody Drug Conjugates Sales Market Share by Application (2017-2022)

Table 41. APAC Cancer Antibody Drug Conjugates Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Cancer Antibody Drug Conjugates Sales Market Share by Region (2017-2022)

Table 43. APAC Cancer Antibody Drug Conjugates Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Cancer Antibody Drug Conjugates Revenue Market Share by Region (2017-2022)

Table 45. APAC Cancer Antibody Drug Conjugates Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Cancer Antibody Drug Conjugates Sales Market Share by Type (2017-2022)

Table 47. APAC Cancer Antibody Drug Conjugates Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Cancer Antibody Drug Conjugates Sales Market Share by Application (2017-2022)

Table 49. Europe Cancer Antibody Drug Conjugates Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Cancer Antibody Drug Conjugates Sales Market Share by Country (2017-2022)

Table 51. Europe Cancer Antibody Drug Conjugates Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Cancer Antibody Drug Conjugates Revenue Market Share by Country (2017-2022)

Table 53. Europe Cancer Antibody Drug Conjugates Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Cancer Antibody Drug Conjugates Sales Market Share by Type (2017-2022)

Table 55. Europe Cancer Antibody Drug Conjugates Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Cancer Antibody Drug Conjugates Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Cancer Antibody Drug Conjugates Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Cancer Antibody Drug Conjugates Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Cancer Antibody Drug Conjugates Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Cancer Antibody Drug Conjugates Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Cancer Antibody Drug Conjugates Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Cancer Antibody Drug Conjugates Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Cancer Antibody Drug Conjugates Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Cancer Antibody Drug Conjugates Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Cancer Antibody Drug Conjugates

Table 66. Key Market Challenges & Risks of Cancer Antibody Drug Conjugates

Table 67. Key Industry Trends of Cancer Antibody Drug Conjugates

Table 68. Cancer Antibody Drug Conjugates Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Cancer Antibody Drug Conjugates Distributors List

Table 71. Cancer Antibody Drug Conjugates Customer List

Table 72. Global Cancer Antibody Drug Conjugates Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Cancer Antibody Drug Conjugates Sales Market Forecast by Region

Table 74. Global Cancer Antibody Drug Conjugates Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Cancer Antibody Drug Conjugates Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Cancer Antibody Drug Conjugates Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Cancer Antibody Drug Conjugates Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Cancer Antibody Drug Conjugates Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Cancer Antibody Drug Conjugates Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Cancer Antibody Drug Conjugates Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Cancer Antibody Drug Conjugates Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Cancer Antibody Drug Conjugates Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Cancer Antibody Drug Conjugates Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Cancer Antibody Drug Conjugates Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Cancer Antibody Drug Conjugates Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Cancer Antibody Drug Conjugates Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Cancer Antibody Drug Conjugates Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Cancer Antibody Drug Conjugates Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Cancer Antibody Drug Conjugates Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Cancer Antibody Drug Conjugates Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Cancer Antibody Drug Conjugates Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novartis Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 93. Novartis Cancer Antibody Drug Conjugates Product Offered

Table 94. Novartis Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Novartis Main Business

Table 96. Novartis Latest Developments

Table 97. Merck Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Cancer Antibody Drug Conjugates Product Offered

Table 99. Merck Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Merck Main Business

Table 101. Merck Latest Developments

Table 102. Roche Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 103. Roche Cancer Antibody Drug Conjugates Product Offered

Table 104. Roche Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Roche Main Business

Table 106. Roche Latest Developments

Table 107. AbbVie Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 108. AbbVie Cancer Antibody Drug Conjugates Product Offered

Table 109. AbbVie Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. AbbVie Main Business

Table 111. AbbVie Latest Developments

Table 112. UCB Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 113. UCB Cancer Antibody Drug Conjugates Product Offered

Table 114. UCB Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. UCB Main Business

Table 116. UCB Latest Developments

Table 117. Bristol-Myers Squibb Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 118. Bristol-Myers Squibb Cancer Antibody Drug Conjugates Product Offered

Table 119. Bristol-Myers Squibb Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Bristol-Myers Squibb Main Business

Table 121. Bristol-Myers Squibb Latest Developments

Table 122. Stem CentRx Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 123. Stem CentRx Cancer Antibody Drug Conjugates Product Offered

Table 124. Stem CentRx Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. Stem CentRx Main Business

Table 126. Stem CentRx Latest Developments

Table 127. Biogen Idec Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 128. Biogen Idec Cancer Antibody Drug Conjugates Product Offered

Table 129. Biogen Idec Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. Biogen Idec Main Business

Table 131. Biogen Idec Latest Developments

Table 132. Nordic Nanovector Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 133. Nordic Nanovector Cancer Antibody Drug Conjugates Product Offered

Table 134. Nordic Nanovector Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Nordic Nanovector Main Business

Table 136. Nordic Nanovector Latest Developments

Table 137. Millennium Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 138. Millennium Cancer Antibody Drug Conjugates Product Offered

Table 139. Millennium Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Millennium Main Business

Table 141. Millennium Latest Developments

Table 142. Biotest AG Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 143. Biotest AG Cancer Antibody Drug Conjugates Product Offered

Table 144. Biotest AG Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Biotest AG Main Business

Table 146. Biotest AG Latest Developments

Table 147. PDL BioPharma Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 148. PDL BioPharma Cancer Antibody Drug Conjugates Product Offered

Table 149. PDL BioPharma Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 150. PDL BioPharma Main Business

Table 151. PDL BioPharma Latest Developments

Table 152. Progenics Pharmaceuticals Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 153. Progenics Pharmaceuticals Cancer Antibody Drug Conjugates Product Offered

Table 154. Progenics Pharmaceuticals Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 155. Progenics Pharmaceuticals Main Business

Table 156. Progenics Pharmaceuticals Latest Developments

Table 157. Seattle Genetics Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 158. Seattle Genetics Cancer Antibody Drug Conjugates Product Offered

Table 159. Seattle Genetics Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 160. Seattle Genetics Main Business

Table 161. Seattle Genetics Latest Developments

Table 162. Viventia Biotechnologies Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 163. Viventia Biotechnologies Cancer Antibody Drug Conjugates Product Offered

Table 164. Viventia Biotechnologies Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 165. Viventia Biotechnologies Main Business

Table 166. Viventia Biotechnologies Latest Developments

Table 167. AbGenomics Corporation Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 168. AbGenomics Corporation Cancer Antibody Drug Conjugates Product Offered

Table 169. AbGenomics Corporation Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 170. AbGenomics Corporation Main Business

Table 171. AbGenomics Corporation Latest Developments

Table 172. Helix BioPharma Basic Information, Cancer Antibody Drug Conjugates Manufacturing Base, Sales Area and Its Competitors

Table 173. Helix BioPharma Cancer Antibody Drug Conjugates Product Offered

Table 174. Helix BioPharma Cancer Antibody Drug Conjugates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 175. Helix BioPharma Main Business

Table 176. Helix BioPharma Latest Developments

List of Figures

Figure 1. Picture of Cancer Antibody Drug Conjugates

Figure 2. Cancer Antibody Drug Conjugates Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cancer Antibody Drug Conjugates Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Cancer Antibody Drug Conjugates Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cancer Antibody Drug Conjugates Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of First & Second Generation ADCs

Figure 10. Product Picture of Third Generation ADCs

Figure 11. Global Cancer Antibody Drug Conjugates Sales Market Share by Type in 2021

Figure 12. Global Cancer Antibody Drug Conjugates Revenue Market Share by Type (2017-2022)

Figure 13. Cancer Antibody Drug Conjugates Consumed in Hospitals

Figure 14. Global Cancer Antibody Drug Conjugates Market: Hospitals (2017-2022) & (K Pcs)

Figure 15. Cancer Antibody Drug Conjugates Consumed in Clinics

Figure 16. Global Cancer Antibody Drug Conjugates Market: Clinics (2017-2022) & (K Pcs)

Figure 17. Cancer Antibody Drug Conjugates Consumed in Others

Figure 18. Global Cancer Antibody Drug Conjugates Market: Others (2017-2022) & (K Pcs)

Figure 19. Global Cancer Antibody Drug Conjugates Sales Market Share by Application (2017-2022)

Figure 20. Global Cancer Antibody Drug Conjugates Revenue Market Share by Application in 2021

Figure 21. Cancer Antibody Drug Conjugates Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Cancer Antibody Drug Conjugates Revenue Market Share by Company in 2021

Figure 23. Global Cancer Antibody Drug Conjugates Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Cancer Antibody Drug Conjugates Revenue Market Share by Geographic Region in 2021

Figure 25. Global Cancer Antibody Drug Conjugates Sales Market Share by Region (2017-2022)

Figure 26. Global Cancer Antibody Drug Conjugates Revenue Market Share by Country/Region in 2021

Figure 27. Americas Cancer Antibody Drug Conjugates Sales 2017-2022 (K Pcs)

Figure 28. Americas Cancer Antibody Drug Conjugates Revenue 2017-2022 ($ Millions)

Figure 29. APAC Cancer Antibody Drug Conjugates Sales 2017-2022 (K Pcs)

Figure 30. APAC Cancer Antibody Drug Conjugates Revenue 2017-2022 ($ Millions)

Figure 31. Europe Cancer Antibody Drug Conjugates Sales 2017-2022 (K Pcs)

Figure 32. Europe Cancer Antibody Drug Conjugates Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Cancer Antibody Drug Conjugates Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Cancer Antibody Drug Conjugates Revenue 2017-2022 ($ Millions)

Figure 35. Americas Cancer Antibody Drug Conjugates Sales Market Share by Country in 2021

Figure 36. Americas Cancer Antibody Drug Conjugates Revenue Market Share by Country in 2021

Figure 37. United States Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Cancer Antibody Drug Conjugates Sales Market Share by Region in 2021

Figure 42. APAC Cancer Antibody Drug Conjugates Revenue Market Share by Regions in 2021

Figure 43. China Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Cancer Antibody Drug Conjugates Sales Market Share by Country in 2021

Figure 50. Europe Cancer Antibody Drug Conjugates Revenue Market Share by Country in 2021

Figure 51. Germany Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Cancer Antibody Drug Conjugates Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Cancer Antibody Drug Conjugates Revenue Market Share by Country in 2021

Figure 58. Egypt Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Cancer Antibody Drug Conjugates Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Cancer Antibody Drug Conjugates in 2021

Figure 64. Manufacturing Process Analysis of Cancer Antibody Drug Conjugates

Figure 65. Industry Chain Structure of Cancer Antibody Drug Conjugates

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles